| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Secukinumab |
| Brand | Cosentyx® |
| Indication | For the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therapy |
| Assessment Process | |
| Rapid review commissioned | 02/12/2015 |
| Rapid review completed | 14/12/2015 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |
The HSE has approved reimbursement following confidential price negotiations.